We have recently isolated a novel C-type cyclin (called Cyclin T) which interacts directly with HIV-1 Tat through its activation domain. Cyclin T (CycT) is a predominant cyclin partner for CDK9 (PITALRE), the catalytic subunit of the positive-acting transcription elongation factor complex, P-TEFb. We determined that the interaction of Tat with CycT dramatically enhances its binding to TAR RNA, and confers a requirement for critical sequences in the loop of TAR which are not recognized by the free (uncomplexed) Tat protein. Structure-function analysis of the cyclin T:Tat interaction. Here we propose to characterize the interaction between Tat and CycT in molecular detail, and to identify other factors present in the Tat-associated kinase (TAK)/P-TEFb complex that may be required for the regulation of transcription elongation by Tat.
In Specific Aim 1 we will identify residues within CycT and in Tat that are necessary for their interaction and for binding to Tar RNA using site-directed mutagenesis and UV cross-linking techniques.
In Specific Aim 2, we will analyze the ability of wild-type and mutant CycT proteins to support basal and Tat-mediated transactivation in vivo and in cell-free transcription reactions that have been immunodepleted of hCycT, or blocked with trans-dominant Tat (1-48) protein. We will also determine whether additional P-TEFb components are needed for Tat activity. We have recently cloned the murine CycT protein (mCycT) and find that it is unable to support Tat transactivation through TAR.
In Specific Aim 3, we will characterize the defect in mCycT and identify the minimal changes needed to restore Tat transactivation in vivo. Finally, in Specific Aims 4 and 5 we propose to clone and characterize two novel proteins which we find to be tightly associated with TAK/P- TEFb in nuclear extracts, either alone or when bound to TAR RNA. Taken together, these studies will provide important new information on the mechanism of HIV Tat transactivation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI044615-02
Application #
6124286
Study Section
Special Emphasis Panel (ZRG5-AARR-1 (01))
Program Officer
Plaeger, Susan F
Project Start
1998-12-01
Project End
2003-11-30
Budget Start
1999-12-01
Budget End
2000-11-30
Support Year
2
Fiscal Year
2000
Total Cost
$423,380
Indirect Cost
Name
Salk Institute for Biological Studies
Department
Type
DUNS #
005436803
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Chen, Yupeng; Zhang, Lirong; Estarás, Conchi et al. (2014) A gene-specific role for the Ssu72 RNAPII CTD phosphatase in HIV-1 Tat transactivation. Genes Dev 28:2261-75
Brès, Vanessa; Yoshida, Tomonori; Pickle, Loni et al. (2009) SKIP interacts with c-Myc and Menin to promote HIV-1 Tat transactivation. Mol Cell 36:75-87
Yoh, Sunnie M; Lucas, Joseph S; Jones, Katherine A (2008) The Iws1:Spt6:CTD complex controls cotranscriptional mRNA biosynthesis and HYPB/Setd2-mediated histone H3K36 methylation. Genes Dev 22:3422-34
Bres, Vanessa; Yoh, Sunnie M; Jones, Katherine A (2008) The multi-tasking P-TEFb complex. Curr Opin Cell Biol 20:334-40
Yoh, Sunnie M; Cho, Helen; Pickle, Loni et al. (2007) The Spt6 SH2 domain binds Ser2-P RNAPII to direct Iws1-dependent mRNA splicing and export. Genes Dev 21:160-74
Garber, M E; Jones, K A (1999) HIV-1 Tat: coping with negative elongation factors. Curr Opin Immunol 11:460-5
Garber, M E; Wei, P; Jones, K A (1998) HIV-1 Tat interacts with cyclin T1 to direct the P-TEFb CTD kinase complex to TAR RNA. Cold Spring Harb Symp Quant Biol 63:371-80